Physician profile
Timothy Cooper Kunkle
NPI 1295000156
$2,814.81
in general payments reported to CMS, 2019-2025
8 companies · $421 in 2025
The $421 reported for 2025 was more than what 75% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $65.98 · 2021: $24.33 · 2023: $90.37 · 2024: $403 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635 · Entertainment: $265 · Education: $13.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.40 |
| Entertainment | $265.23 |
| Education | $13.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,887.12 | 2019-2024 | |
| Zimvie INC. | $349.95 | 2023-2025 | |
| Keystone Dental INC. | $265.23 | 2025 | |
| Geistlich Pharma, North America, INC. | $148.29 | 2020-2025 | Geistlich Bio-Gide, Biomaterials |
| Zimmer Biomet Holdings, INC. | $90.91 | 2019 | |
| Southern Implants North America INC | $34.29 | 2024 | |
| 3m Company | $25.91 | 2023 | 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, Filtek |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kunkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.